|
|
Michael Johnston: Despite some rather significant bumps along the road in 2011, many asset classes are now well into positive territory on a one year trailing basis as January draws to a close, riding high thanks to a strong finish to last year and start to 2012. Included on that list are a number of Read more…
IBB, LBND, NASDAQ:BIB, TYD, UGL
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
IBB, NASDAQ:BIB, NASDAQ:BIS, NYSE:FBT, PBE, XBI
I’m a momentum investor. What does that mean? I just try to identify leading market sectors and then keep my portfolio aligned with them. Sometimes the strength is fairly obvious, and at other Read more…
IBB, IHF, NASDAQ:BIB, NYSE:PPH, PTH
David Fry From ETF Digest goes into detail on two biotech ETFs discussing the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the ProShares Ultra Nasdaq Biotechnology ETF Read more…
ProShares, the leading manager of leveraged and inverse ETFs, announced today that it is launching the first ETFs with leveraged and inverse exposure to the biotechnology sector. The ETFs seek to provide 200% or -200% of the return of the NASDAQ Biotechnology Index® for a single day. Read more…
ProShares has filed paperwork with the SEC for an Ultra Nasdaq Biotechnology ETF. There is no symbol noted at this time. The ProShares Ultra Nasdaq Biotechnology (the “Fund”) will seek Read more…
Most Comments